Core Laboratories N.V. (NYSE:CLB) Sellers Reduced By 10.68% Their Shorts As Of Apr 16, 2018

April 16, 2018 - By Brian Ramirez

Core Laboratories N.V. (NYSE:CLB) Corporate Logo

During Q4 2017 the big money sentiment decreased to 0.86. That’s change of 0.21, from 2017Q3’s 1.07. 52 investors sold all, 109 reduced holdings as Core Laboratories N.V. ratio turned negative. 85 grew holdings while 54 funds took holdings. Funds hold 49.56 million shares thus 0.63% more from 2017Q3’s 49.25 million shares.
Moors And Cabot Incorporated reported 19,316 shs. The Texas-based Dimensional Fund L P has invested 0.01% in Core Laboratories N.V. (NYSE:CLB). Citadel Limited Liability Com has 0.01% invested in Core Laboratories N.V. (NYSE:CLB). Van Eck Assoc reported 682,194 shs stake. Monroe Retail Bank And Trust Mi stated it has 8,938 shs. Eagle Asset Mgmt Inc accumulated 84,300 shs. Profund Advsrs Limited Liability owns 7,593 shs. Brinker Cap Inc invested 0.11% in Core Laboratories N.V. (NYSE:CLB). Penbrook Ltd Liability Company reported 1.09% stake. Moneta Group Invest Advisors Ltd reported 2,000 shs. Btr Capital stated it has 9,630 shs or 0.21% of all its holdings. Park National Corp Oh invested 0.01% in Core Laboratories N.V. (NYSE:CLB). Conestoga Cap Advsrs Limited Com holds 0.05% or 12,307 shs. 67,622 were accumulated by Shufro Rose &. Moreover, Boston Private Wealth Ltd has 0.01% invested in Core Laboratories N.V. (NYSE:CLB).

Change of 10.68% for Core Laboratories N.V. (NYSE:CLB)’s short interest was recorded. FINRA issued in April CLB’s total 6.96 million short interest. That’s 10.68% down from 7.80M shares. 18 days will cost CLB With 398,700 average volume to recover its former position. Float short on Core Laboratories N.V. is 16.03%.

On during the last trading session the stock increased $0.56 or 0.48%, reaching $117.31.Core Laboratories N.V. has volume of 29,065 shares. Since April 16, 2017 CLB has declined 4.05% and is downtrending. The stock underperformed the S&P500 by 15.60%.

Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the gas and oil industry in the United States, Canada, and internationally.The firm is worth $5.18 billion. It operates through three divisions: Reservoir Description, Production Enhancement, and Reservoir Management.62.4 is the P/E ratio. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples.

Core Laboratories N.V. (NYSE:CLB) Ratings Coverage

In total 7 analysts cover Core Laboratories (NYSE:CLB). “Buy” rating has 3, “Sell” are 0, while 4 are “Hold”. 43% are bullish. 9 are the (NYSE:CLB)’s analyst reports since October 23, 2017 according to StockzIntelligence Inc. The stock rating was maintained by RBC Capital Markets with “Buy” on Monday, January 29. On Wednesday, October 25 the stock of Core Laboratories N.V. (NYSE:CLB) earned “Buy” rating by ABN Amro. On Friday, April 13 Cowen & Co maintained Core Laboratories N.V. (NYSE:CLB) rating. Cowen & Co has “Hold” rating and $9800 target. On Thursday, January 11 the stock of Core Laboratories N.V. (NYSE:CLB) has “Hold” rating given by Deutsche Bank. On Wednesday, October 25 the firm has “Neutral” rating given by UBS. On Thursday, December 21 the rating was maintained by RBC Capital Markets with “Buy”. On Monday, October 23 the firm has “Hold” rating by Piper Jaffray given. On Tuesday, March 13 the firm earned “Hold” rating by Piper Jaffray.

Core Laboratories N.V. (NYSE:CLB) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: